Literature DB >> 15611458

Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.

Stephen R Grobmyer1, Yuman Fong, Michael D'Angelica, Ronald P Dematteo, Leslie H Blumgart, William R Jarnagin.   

Abstract

HYPOTHESES: (1) A clinical risk score (CRS) is useful in selecting patients for diagnostic laparoscopy prior to planned resection of colorectal metastasis. (2) Preventing unnecessary celiotomy in these patients undergoing laparoscopy is associated with shorter hospital stays and earlier administration of systemic chemotherapy.
DESIGN: Retrospective analysis of data collected in a prospective database.
SETTING: Tertiary cancer hospital. PATIENTS: Two hundred seventy-six patients who underwent laparoscopy prior to planned partial hepatic resection (n = 264) for colorectal metastases or prior to hepatic artery infusion pump placement for colorectal metastases (n = 12). MAIN OUTCOME MEASURES: The yield of laparoscopy for patients with potentially resectable tumors was analyzed in the context of a CRS, calculated by assigning 1 point for each of the following adverse, disease-related factors: lymph node-positive primary tumor, disease-free interval less than 12 months, more than 1 hepatic tumor, hepatic tumor greater than 5 cm, and cardio embryonic antigen level less than 200 ng/mL. The CRS represents the sum for each patient. Length of hospital stay and time to initiation of chemotherapy were compared in those patients determined to be unresectable.
RESULTS: Staging laparoscopy prevented nontherapeutic celiotomy in 10% of patients submitted to operation for a potentially curative partial hepatectomy (26 of 264) and in 33% of patients scheduled for pump placement only (4/12). The CRS correlated closely with the likelihood of identifying radiographically occult unresectable disease: 0 or 1, 4%; 2 or 3, 21%; and 4 or 5, 38%. Likewise, the percentage of patients avoiding an unnecessary celiotomy increased progressively with increasing CRS: 0 or 1, 0%; 2 or 3, 11%; and 4 or 5, 24%. Preventing an unnecessary celiotomy with laparoscopy was associated with a decreased length of hospital stay (P<.01) and earlier initiation of chemotherapy (P = .045).
CONCLUSIONS: Diagnostic laparoscopy does not need to be performed routinely in all patients prior to hepatic resection for colorectal cancer metastasis. Laparoscopy has a very low yield in patients with a CRS of 1 or less and is unnecessary. The yield of laparoscopy increases with increasing CRS. Preventing celiotomy with laparoscopy is associated with a decreased length of hospital stay and earlier initiation of postoperative chemotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15611458     DOI: 10.1001/archsurg.139.12.1326

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  20 in total

1.  Surgical management of colorectal liver metastases.

Authors:  Waleed M Mohammad; Fady K Balaa
Journal:  Clin Colon Rectal Surg       Date:  2009-11

2.  Liver resection with intraoperative and laparoscopic ultrasound: report of 32 cases : Ultrasonic shears device for liver parenchymal transection.

Authors:  Domenico Piccolboni; Francesco Ciccone; Anna Settembre; Francesco Corcione
Journal:  Surg Endosc       Date:  2008-04-10       Impact factor: 4.584

3.  Laparoscopic approaches to rectal cancer.

Authors:  Bradley J Champagne; Conor P Delaney
Journal:  Clin Colon Rectal Surg       Date:  2007-08

4.  Feasibility of laparoscopic portal vein ligation prior to major hepatectomy.

Authors:  C Are; S Iacovitti; F Prete; F M Crafa
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Intraoperative confocal laser endomicroscopy for real-time in vivo tissue characterization during surgical procedures.

Authors:  David Fuks; Angelo Pierangelo; Pierre Validire; Marine Lefevre; Abdelali Benali; Guillaume Trebuchet; Aline Criton; Brice Gayet
Journal:  Surg Endosc       Date:  2018-09-19       Impact factor: 4.584

6.  Stereotactic excision of additional lesions detected with intraoperative ultrasound examination during radiofrequency dissecting sealar (habib®) assisted hepatic metastasectomy: report of 4 cases.

Authors:  Yunus E Altuntas; Sacide Unel; Fazlı C Gezen; Nihat Aksakal; Osman Civil; Selahattin Vural; Mustafa Ozates; Mustafa Oncel
Journal:  Indian J Surg       Date:  2012-06-20       Impact factor: 0.656

7.  Diagnostic accuracy of confocal laser endomicroscopy for the ex vivo characterization of peritoneal nodules during laparoscopic surgery.

Authors:  Angelo Pierangelo; David Fuks; Abdelali Benali; Pierre Validire; Brice Gayet
Journal:  Surg Endosc       Date:  2016-08-17       Impact factor: 4.584

8.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 9.  Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.

Authors:  Yolanda Y L Yang; James W Fleshman; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

10.  Laparoscopic staging in selected patients with colorectal liver metastases as a prelude to liver resection.

Authors:  Sophie A Pilkington; Myrddin Rees; Delia Peppercorn; Timothy G John
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.